Prevention and management of hypertrophic scars and keloids after burns in children

被引:104
作者
Berman, Brian [1 ]
Viera, Martha H. [1 ]
Amini, Sadegh [1 ]
Huo, Ran [1 ]
Jones, Isaac S. [1 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA
关键词
hypertrophic scars; keloids; postburn scars; prevention and management;
D O I
10.1097/SCS.0b013e318175f3a7
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hypertrophic scars and keloids are challenging to manage, particularly as sequelae. of bums in children in whom the psychologic burden and skin characteristics differ substantially from adults. Prevention of hypertrophic scars and keloids after burns is currently the best strategy in their management to avoid permanent functional and aesthetical alterations. Several actions can be taken to prevent their occurrence, including parental and children education regarding handling sources of fire and flammable materials, among others. Combination of therapies is the mainstay of current burn scar management, including surgical reconstruction, pressure therapy, silicon gels and sheets, and temporary garments. Other adjuvant therapies such as topical imiquimod, tacrolimus, and retinoids, as well as intralesional corticosteroids, 5-fluorouracil, interferons, and bleomycin, have been used with relative success. Cryosurgery and lasers have also been reported as alternatives. Newer treatments aimed at molecular targets such as cytokines, growth factors, and gene therapy, currently in developing stages, are considered the future of the treatment of postburn hypertrophic scars and keloids in children.
引用
收藏
页码:989 / 1006
页数:18
相关论文
共 299 条
  • [1] Abdel-Wahab N, 2002, BIOCHEM J, V366, P999
  • [2] Decorin suppresses transforming growth factor-β-induced expression of plasminogen activator inhibitor-1 in human mesangial cells through a mechanism that involves Ca2+-dependent phosphorylation of Smad2 at serine-240
    Abdel-Wahab, N
    Wicks, SJ
    Mason, RM
    Chantry, A
    [J]. BIOCHEMICAL JOURNAL, 2002, 362 (03) : 643 - 649
  • [3] CONTROL OF CONNECTIVE-TISSUE METABOLISM BY LASERS - RECENT DEVELOPMENTS AND FUTURE-PROSPECTS
    ABERGEL, RP
    MEEKER, CA
    LAM, TS
    DWYER, RM
    LESAVOY, MA
    UITTO, J
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1984, 11 (06) : 1142 - 1150
  • [4] RETINOID MODULATION OF CONNECTIVE-TISSUE METABOLISM IN KELOID FIBROBLAST-CULTURES
    ABERGEL, RP
    MEEKER, CA
    OIKARINEN, H
    OIKARINEN, AI
    UITTO, J
    [J]. ARCHIVES OF DERMATOLOGY, 1985, 121 (05) : 632 - 635
  • [5] AHN ST, 1991, ARCH SURG-CHICAGO, V126, P499
  • [6] The quality of pediatric burn scars is improved by early administration of basic fibroblast growth factor
    Akita, Sadanori
    Akino, Kozo
    Imaizumi, Toshifumi
    Tanaka, Katsumi
    Anraku, Kuniaki
    Yano, Hiroki
    Hirano, Akiyoshi
    [J]. JOURNAL OF BURN CARE & RESEARCH, 2006, 27 (03) : 333 - 338
  • [7] Keloid pathogenesis and treatment
    Al-Attar, A
    Mess, S
    Thomassen, JM
    Kauffman, CL
    Davison, SP
    [J]. PLASTIC AND RECONSTRUCTIVE SURGERY, 2006, 117 (01) : 286 - 300
  • [8] HYALURONIC-ACID METABOLISM IN KELOID FIBROBLASTS
    ALAISH, SM
    YAGER, DR
    DIEGELMANN, RF
    COHEN, IK
    [J]. JOURNAL OF PEDIATRIC SURGERY, 1995, 30 (07) : 949 - 952
  • [9] Failure of interferon-alpha 2B in the treatment of mature keloids
    AlKhawajah, MM
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 1996, 35 (07) : 515 - 517
  • [10] Laser scar revision: Comparison study of 585-nm pulsed dye laser with and without intralesional corticosteroids
    Alster, T
    [J]. DERMATOLOGIC SURGERY, 2003, 29 (01) : 25 - 29